³Ô¹ÏÍøÕ¾

Latest clinical trial News

WHO and partners enable access to candidate vaccine and treatments for outbreak of Sudan Ebola virus disease in Uganda
IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess(TM))
New link revealed between hypertension and the gut
For tennis star Destanee Aiava, borderline personality disorder felt like ‘a death sentence’ – and a relief. What is it?
Heather’s Bowel Cancer Diagnosis – Despite No Symptoms
Radiopharmaceuticals being tested for brain tumours in children
Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of…
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
Live in the Dubbo region and feeling burned out? Join a clinical trial
UQ manufactures 3D printed scaffolding to rebuild jaw bones
2025 will see huge advances in quantum computing. So what is a quantum chip and how does it work?
CUREator + deploys $18.5 million in its first funding round
Clinical trial aims to ease pain of pelvic venous disorders
Major health grants win for Victoria University researchers
If you have ovarian cancer, genomic testing may open up new treatment options
Groundbreaking Defibrillator Trial Helps Save Young Mum
HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
Stem Cells: Hope on the Horizon for Preterm Babies
Stem Cells: Hope On Horizon For Preterm Babies
Brain inflammation may be the reason behind muscle fatigue after infection and injury
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
Drug delivery innovation to power next-generation cancer treatment
AusBiotech and BioMelbourne Network welcome the Victorian Government’s Economic Growth Statement
Anticancer drugs could make immunotherapies more effective
FivepHusion secures ethics approval of a Phase 1b deflexifol clinical trial
Recce receives approval from Indonesia’s regulator for registrational Phase 3 clinical trial
Major Milestone For UQ Spin-out’s Promising MND Drug
Does menopause hormone therapy increase or decrease your risk of dementia? Here’s the science
Adults grow new brain cells – and these neurons are key to learning by listening
Long-term benefit from anti-hormonal treatment is influenced by menopausal status
Parkinson’s researchers call for people who act out their dreams for world-first trial
Precision Medicine Transforming Treatment For Corneal Blindness
Long COVID appears to be driven by ‘long infection’. Here’s what the science says
Researchers discover new treatment for rare immune disease
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
QIMR Berghofer depression discovery brings fresh hope for ‘melancholia’
Largest-ever global study of bloodstream infection reveals long courses of antibiotics in hospital may not be required
RNA editing is the next frontier in gene therapy – here’s what you need to know
Lake Macquarie Private Hospital becomes first Australian site to join new breast cancer trial
Neurizon Therapeutics says candidate reduces aggregation of key ALS disease target
Monash-led research is expanding treatment options for high cholesterol
Promising daily tablet increases growth in children with dwarfism
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
Funding Gift For Spinal Injury Clinical Trial
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
MEB Receives 86 Millions In Swedish Grants
³Ô¹ÏÍøÕ¾ Anti-vaping Program For Young Australians
‘Sleepy cannabis’: first objective study to show cannabinol increases sleep